Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL3 | 35.5 | 36 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | IL3 | 36.0 | 40 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL3 | 52.0 | 23 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | IL3 | 31.0 | 42 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL3 | 43.5 | 46 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL3 | 36.0 | 44 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | IL3 | 28.5 | 40 | ||||
RA1869 | 1 | IL3 | 28.5 | 32 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | IL3 | 48.0 | 37 | ||||
N2759 | 1 | IL3 | 31.0 | 31 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | IL3 | 60.0 | 22 | ||||
RA1931 | 1 | IL3 | 50.0 | 32 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL3 | 39.5 | 40 | ||||
N2586 | 1 | IL3 | 53.5 | 46 | |||||||
0 | IL3 | 40.0 | 23 | ||||||||
0 | IL3 | 51.5 | 42 | ||||||||
0 | IL3 | 58.0 | 33 | ||||||||
0 | IL3 | 103.0 | 35 | ||||||||
0 | IL3 | 133.0 | 29 | ||||||||
0 | IL3 | 102.5 | 30 | ||||||||
RA2159 | 2 | IL3 | 65.0 | 46 | |||||||
N2645 | 2 | IL3 | 62.0 | 59 | |||||||
RA2708 | 2 | IL3 | 64.0 | 47 | |||||||
RA2159 | JNK-IN-8 | 3.0 | uM | 2 | IL3 | 58.0 | 30 | ||||
RA2159 | PH-797804 | 0.6 | uM | 2 | IL3 | 48.0 | 50 |